diagnost
test
respiratori
viral
infect
use
tradit
either
nasopharyng
wash
swab
sputum
repres
lower
respiratori
tract
use
rare
viral
test
aim
studi
compar
detect
rate
respiratori
virus
nasopharyng
swab
sputum
use
multiplex
realtim
revers
transcriptionpolymeras
chain
reaction
rtpcr
adult
admit
present
clinic
gil
medic
center
acut
respiratori
symptom
recruit
novemb
march
pair
specimen
nasopharyng
swab
sputum
obtain
subject
rna
extract
test
differ
respiratori
virus
use
anyplex
ii
detect
kit
seegen
seoul
korea
posit
rate
nasopharyng
swab
sputum
p
one
hundr
thirtyfour
virus
identifi
ill
influenza
viru
rsv
hrv
coronaviru
adenoviru
detect
frequent
sputum
sampl
nasopharyng
swab
p
importantli
influenza
infect
rsv
infect
posit
sputum
sampl
detect
rate
respiratori
virus
sputum
sampl
significantli
higher
nasopharyng
swab
adult
use
realtim
multiplex
rtpcr
find
suggest
sputum
would
benefit
detect
respiratori
virus
nucleic
acid
amplif
test
naat
patient
produc
sputum
studi
need
establish
standard
rna
extract
method
sputum
sampl
respiratori
viral
infect
rang
mild
upper
respiratori
tract
infect
sever
lower
respiratori
infect
major
caus
morbid
diseas
sever
affect
hostand
viralpredispos
factor
clinic
impact
respiratori
virus
increas
young
children
elderli
immunocompromis
host
patient
underli
diseas
monto
rapid
identif
respiratori
viral
infect
critic
avoid
use
unnecessari
antibiot
use
appropri
antivir
agent
minim
risk
nosocomi
transmiss
reduc
overal
cost
patient
manag
et
al
diagnosi
respiratori
viral
infect
perform
tradit
use
viru
cultur
direct
antigen
assay
storch
cultur
often
consid
gold
standard
laborintens
timeconsum
antigen
detect
assay
simpl
sometim
insuffici
sensit
molecular
techniqu
use
current
respiratori
viru
detect
improv
sensit
multiplex
realtim
revers
transcriptionpolymeras
chain
reaction
rtpcr
method
detect
simultan
number
virus
singl
assay
sputum
use
rare
tradit
viral
test
due
viscou
natur
make
sampl
process
difficult
howev
advent
molecular
method
sputum
introduc
diagnosi
respiratori
viral
infect
aim
studi
compar
detect
rate
respiratori
virus
pair
nasopharyng
swab
sputum
sampl
adult
patient
respiratori
symptom
use
multiplex
realtim
rtpcr
adult
year
age
admit
present
clinic
gil
medic
center
sign
symptom
acut
respiratori
ill
defin
cough
rhinorrhoea
nasal
congest
dyspnoea
sputum
fever
recruit
novemb
march
pair
specimen
nasopharyng
swab
sputum
obtain
subject
patient
provid
written
inform
consent
institut
review
board
gil
medic
center
approv
studi
enrol
clinic
radiolog
laboratori
inform
collect
sputum
sampl
expector
spontan
steril
contain
deliv
laboratori
within
hr
sputum
sampl
dilut
equal
volum
phosphat
buffer
salin
pb
mix
vortex
min
depend
sputum
viscos
rtpcr
result
invalid
retest
perform
use
specimen
dilut
twice
initi
volum
pb
nasopharyng
swab
obtain
patient
physician
use
flock
swab
copan
diagnost
brescia
itali
transport
ml
univers
transport
medium
utm
copan
diagnost
prospect
collect
sputum
nasopharyng
swab
sampl
test
simultan
rna
extract
ml
sampl
ml
bacteriophag
intern
control
use
geneal
ribospin
kit
geneal
biotechnolog
seoul
korea
intern
control
ad
specimen
exogen
control
check
entir
process
nucleic
acid
extract
rtpcr
final
elut
volum
sampl
ml
autom
protocol
extract
rtpcr
pcr
setup
implement
use
nimbu
hamilton
robot
reno
nv
autom
liquid
handl
workstat
maxim
workflow
accuraci
multiplex
realtim
rtpcr
perform
use
anyplex
ii
rv
detect
kit
seegen
seoul
korea
accord
manufactur
instruct
sputum
sampl
nasopharyng
specimen
patient
test
parallel
follow
respiratori
virus
human
bocaviru
hbov
human
enteroviru
hev
influenza
viru
b
parainfluenza
viru
piv
piv
piv
piv
rsv
b
rsv
rsv
b
adenoviru
adv
metapneumoviru
mpv
coronaviru
coronaviru
coronaviru
human
rhinoviru
abc
hrv
overal
posit
rate
virus
nasopharyng
swab
sputum
sampl
compar
use
mcnemar
test
clinic
characterist
patient
diagnost
yield
detect
viru
two
specimen
compar
use
chisquar
test
fisher
exact
test
statist
signific
set
p
valu
agreement
result
nasopharyng
swab
sputum
specimen
assess
use
kappa
statist
cohen
kappa
coeffici
k
landi
koch
statist
analys
perform
use
spss
version
spss
inc
ibm
compani
chicago
il
pair
nasopharyng
swab
sputum
sampl
collect
patient
clinic
characterist
patient
shown
tabl
patient
includ
male
femal
median
age
year
interquartil
rang
year
approxim
patient
underli
chronic
pulmonari
diseas
patient
troubl
respiratori
symptom
median
day
prior
sampl
tabl
respiratori
viral
infect
identifi
patient
tabl
ii
posit
rate
nasopharyng
swab
sputum
sputum
show
significantli
higher
posit
rate
nasopharyng
swab
detect
respiratori
virus
p
viral
coinfect
found
nasopharyng
swab
sputum
tabl
iii
nasopharyng
swab
singl
viru
identifi
case
two
virus
four
case
three
virus
one
case
sputum
singl
viru
identifi
case
two
virus
case
three
virus
three
case
tabl
iii
overal
distribut
detect
respiratori
virus
shown
tabl
iv
one
hundr
thirtyfour
virus
identifi
ill
influenza
viru
common
follow
rsv
hrv
diagnost
yield
detect
viru
nasopharyng
swab
sputum
distribut
posit
result
rang
nasopharyng
swab
test
sputum
test
influenza
viru
rsv
hrv
adv
detect
often
sputum
sampl
nasopharyng
swab
p
virus
number
statist
test
importantli
influenza
infect
rsv
infect
hrv
infect
infect
adv
posit
sputum
sampl
substanti
agreement
nasopharyng
swab
sputum
observ
influenza
viru
rsv
hrv
nearli
perfect
agreement
adv
mpv
poor
agreement
tabl
iv
clinic
characterist
patient
posit
nasopharyng
swab
rtpcr
result
significantli
differ
patient
posit
sputum
rtpcr
result
tabl
v
adequ
specimen
collect
import
diagnosi
respiratori
viral
infect
varieti
upper
respiratori
sampl
includ
nasal
aspir
nasal
swab
nasopharyng
swab
oropharyng
swab
use
commonli
detect
respiratori
virus
earli
studi
suggest
nasal
aspir
superior
swab
specimen
lieberman
et
al
howev
might
true
respiratori
virus
detect
method
addit
sever
studi
shown
respiratori
virus
increasingli
recogn
caus
lower
respiratori
tract
infect
case
lower
respiratori
specimen
collect
detect
respiratori
virus
sputum
repres
lower
respiratori
secret
wide
accept
specimen
diagnosi
bacteri
respiratori
infect
howev
use
rare
detect
respiratori
virus
use
tradit
method
viral
antigen
test
viral
cultur
nucleic
acid
amplif
test
naat
sputum
sampl
use
detect
respiratori
pathogen
current
data
compar
diagnost
yield
nasopharyng
swab
sputum
sampl
respiratori
viru
detect
publish
present
studi
found
overal
detect
rate
sputum
sampl
adult
significantli
higher
nasopharyng
swab
use
multiplex
realtim
rtpcr
find
consist
result
previou
studi
sputum
sampl
show
higher
diagnost
yield
nosethroat
swab
adult
use
rtpcr
falsey
et
al
detect
rate
respiratori
viru
sputum
nasopharyng
swab
respect
gener
hard
compar
detect
rate
respiratori
virus
differ
test
method
specimen
type
upper
lower
airway
swab
wash
nose
throat
flock
regular
swab
type
transport
media
result
still
rel
high
compar
report
lieberman
et
al
falsey
et
al
yu
et
al
differ
explain
sever
factor
first
anyplex
ii
detect
kit
multiplex
realtim
rtpcr
assay
detect
simultan
differ
type
virus
kit
offer
higher
sensit
detect
tradit
diagnos
respiratori
virus
addit
abil
detect
newli
recogn
virus
hbov
piv
hrv
c
second
nasopharyng
sampl
obtain
use
flock
swab
present
studi
known
flock
swab
collect
significantli
epitheli
cell
thu
provid
higher
posit
rate
convent
swab
loen
et
al
third
studi
perform
influenza
outbreak
season
korea
influenza
rsv
respiratori
infect
may
manifest
sever
lower
respiratori
tract
diseas
highrisk
patient
investig
report
falseneg
result
tradit
upper
airway
sampl
patient
respiratori
viral
infect
bogoch
et
al
prior
studi
compar
yield
pair
nosethroat
swab
endotrach
aspir
roa
et
al
current
studi
also
found
influenza
case
detect
nasopharyng
swab
case
detect
sputum
sampl
similarli
rsv
infect
posit
sputum
sampl
find
suggest
tradit
nasopharyng
diagnost
techniqu
miss
case
lower
respiratori
tract
infect
multipl
respiratori
virus
detect
patient
posit
viral
detect
higher
rate
young
children
drew
et
al
kim
et
al
gharabaghi
et
al
zhang
et
al
studi
coinfect
sputum
sampl
common
nasopharyng
swab
vs
one
unanticip
find
influenza
rsv
found
frequent
mix
infect
result
contrari
report
hbov
coronaviru
commonli
associ
multipleag
infect
influenza
viru
rsv
least
often
detect
presenc
anoth
viru
gharabaghi
et
al
differ
explain
part
differ
specimen
type
appli
method
clinic
signific
coinfect
still
unknown
evalu
requir
problem
encount
handl
sputum
naat
first
highli
viscou
natur
sputum
make
nucleic
acid
extract
difficult
therefor
pretreat
sputum
sampl
need
standard
pretreat
procedur
avail
viral
detect
dithiothreitol
nalc
nacetyllcystein
naoh
use
gener
digest
sputum
mycobacteri
laboratori
may
caus
substanti
loss
rna
due
repetit
wash
pipet
step
procedur
desjardin
et
al
xiang
et
al
studi
sputum
sampl
dilut
pb
mix
vortex
volum
time
depend
sputum
viscos
procedur
suffici
sputum
homogen
anoth
problem
naat
inhibitor
respiratori
specimen
may
affect
sensit
assay
lead
falseneg
result
inhibit
amplif
intern
control
note
sputum
sampl
high
proport
compar
nasopharyng
swab
wide
appli
method
remov
pcr
inhibitor
sampl
dilut
may
lead
decreas
inhibitor
present
studi
sampl
show
invalid
pcr
result
dilut
twice
initi
volum
pb
reextract
manual
author
experi
thoroughli
mix
homogen
sputum
sampl
might
import
obtain
valid
result
howev
evalu
nucleic
acid
extract
method
autom
system
sputum
sampl
need
although
sputum
sensit
nasopharyng
swab
respiratori
viral
detect
use
sputum
limit
patient
respiratori
infect
produc
sputum
particularli
elderli
patient
therefor
sputum
sampl
avail
might
reliabl
specimen
respiratori
viral
detect
naat
studi
limit
sputum
sampl
screen
microscop
assess
sputum
qualiti
therefor
contamin
sputum
sampl
upper
respiratori
secret
rule
conclus
detect
rate
respiratori
virus
sputum
sampl
significantli
higher
nasopharyng
swab
adult
use
multipl
realtim
rtpcr
howev
use
sputum
limit
patient
produc
sputum
find
suggest
sputum
would
benefit
detect
respiratori
virus
naat
patient
produc
sputum
studi
need
establish
standard
rna
extract
method
sputum
sampl
